bpc-157 use in dogs Peptides for Pets, Hype, Hope, and What You Must Know In a recent feature in

18 BPC-157 has been studied for over two decades, and the mechanism of action is not clearly known

Over the course of 6 months to a year, people taking GLP-1 medications can typically lose 5% to 10% of their body weight

Dont Use Repeated Freeze-Thaw Cycles Freezing and thawing peptides repeatedly also causes them to degrade (Sigma-Aldrich, 2023a)

So, Im going to see how this goes and see if this is something else I want to add

Transitioning from weight loss to maintenance Determining goal weight achievement: Lost 10-12% body weight (cagrilintide alone) Lost 15-25% body weight (CagriSema) Weight stable for 4-8 weeks Satisfied with current weight Ready to focus on maintenance Maintenance dose options comparison: Option 1: Continue same dose Keep cagrilintide at 2.4mg weekly Ensures no regain Most conservative approach Highest cost Option 2: Reduce dose slightly Decrease to 1.8-2.0mg weekly Monitor weight for 4 weeks If stable, maintain If gaining, increase back 20-25% cost savings Option 3: Try every 10 days Instead of weekly, inject every 10 days Effectively 30% dose reduction Some maintain weight this way Requires close monitoring Recommendation: Try Option 2 first (reduce to 1.8-2.0mg)